Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.
View Top Employees from Sonoma Biotherapeutics| Website | https://www.sonomabio.com |
| Employees | 138 (138 on RocketReach) |
| Founded | 2019 |
| Address | 201 Haskins Way, South San Francisco, California 94080, US |
| Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Immunotherapy, Cell Therapies, Autoimmune Disease, Rheumatoid Arthritis, Inflammatory Diseases, Biotechnology |
Looking for a particular Sonoma Biotherapeutics employee's phone or email?
Sonoma Biotherapeutics Questions
138 people are employed at Sonoma Biotherapeutics.
Sonoma Biotherapeutics is based in South San Francisco, California.
Top Sonoma Biotherapeutics Employees
-
45+
-
55+
-
21
-
21
-
23
-
5+5+
-
42
-
5+5
-
34
Related Companies
